BioCryst shares surged by 40% on positive phase 3 results for their influenza drug Peramivir.It will be interesting to see what sort of bump BTA's sp recieves when LANI phase 3 is released in coming weeks.
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint